Prooxidant And Antioxidant Action Of 4-(4-Phenoxybenzoyl)benzoic Acid Derivatives

    February 2004 in “ Biopolymers ”
    Hassan Y. Aboul-Enein, Alexandra Kladna, Irena Kruk, Krzysztof Lichszteld, Mariola Marchlewicz, Teresa Michalska, Ola I. A. Salem, Rolf W. Hartmann
    Image of study
    TLDR 4-(4-Phenoxybenzoyl)benzoic acid derivatives can both increase and decrease certain types of reactive oxygen species, and may be relevant to hair loss.
    The 2003 study investigated the effects of 4-(4-Phenoxybenzoyl)benzoic acid derivatives (PBADs) on reactive oxygen species. The researchers found that PBADs inhibited rat and human a-reductase isozymes 1 and 2 in vitro, suggesting potential relevance to hair loss. PBADs were found to enhance chemiluminescence from O₂ up to fivefold and increase the production of HO from H₂O₂ up to 90%. They also inhibited the ¹0₂ dependent 2,2,6,6-tetramethylpiperidine-N-oxide radical. The compounds were effective inhibitors of hydroxyl radicals (HO*) and singlet oxygen (¹0₂), but not superoxide radicals (O₂). However, under certain conditions, they also demonstrated prooxidant effects. The researchers suggested that the prooxidant activity of PBADs might contribute to their inhibition of 5a-reductase, an enzyme involved in hair loss, but emphasized the need for further studies.
    Discuss this study in the Community →

    Research cited in this study

    2 / 2 results

    Related Community Posts Join

    6 / 1000+ results

      community 4 months update (fin + min + derma stamps)

      in Progress Pictures  644 upvotes 6 months ago
      The user shared a 4-month update on hair loss treatment using finasteride, minoxidil, and derma stamps, showing significant progress. The user experienced no side effects and plans to continue the treatment, updating monthly.

      community Should I start fin with these blood tests?

      in Finasteride/Dutasteride 1 year ago
      A 25-year-old male is concerned about his blood test results, particularly the low percentage of free testosterone, and is questioning whether starting finasteride for hair loss might worsen this issue. He also notes a slight vitamin D deficiency and lack of sleep before the test.

      community Follicum releases some data from previous phase 2a trial

      in Research/Science  13 upvotes 1 year ago
      Follicum discovered that their drug FOL-005 increased hair count by 12 hairs per cm2 in patients with less than 255 hairs per cm2 and is planning a phase 2b trial. They are currently fundraising for the trial, and the drug may also be effective for women.

    Similar Research

    5 / 1000+ results